Dr Konstantinos Tselios, MD, PhD
Division of Rheumatology
Department of Medicine
Dr. Tselios will present the current knowledge on two new drugs that were successfully tested in phase III clinical trials in lupus. Anifrolumab was recently approved by Health Canada for use in non-renal/non-neuropsychiatric lupus while Voclosporin demonstrated positive effects in patients with lupus nephritis.